Trial intelligence / Profile preview

Autologous adipose-derived mesenchymal stem cells for burn wound treatment

2009-016365-29Phase 2Active

Sponsor
MIGUEL CASARES FERN�NDEZ-ALVÉS
Start
Feb 2010
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of autologous adipose-derived mesenchymal stromal cells in burn injury, sponsored by MIGUEL CASARES FERN�NDEZ-ALVÉS. Primary endpoint: Time to healing. Started Feb 2010; status: active.

02

Drugs

autologous adipose-derived mesenchymal stromal cells
03

Conditions

burn injury

Beyond the preview

Go deeper on 2009-016365-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016365-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call